Xanadu Bio licensed its next-generation nucleic acid delivery platform for vaccination and other applications from Yale University.
For business development inquiries, please contact:Taylor Feehley taylorfeehley@xanadubio.com
For investors, please contact:Marcy Nanus mnanus@trilonadvisors.com